Vitamin D and estradiol can cut down the risk of heart disease, diabetes, and stroke in postmenopausal women, reports a new study. The findings of the study are published in Menopause, the journal of The North American Menopause Society (NAMS).
Vitamin D and estrogen have already shown well-documented results in improving bone health in women. A new study from China suggests that this same combination could help prevent metabolic syndrome, a constellation of conditions that increases the risk of heart disease, stroke, and diabetes in postmenopausal women.
Sunlight: An Important Source of Vitamin D
Vitamin D is an essential vitamin necessary for the development of bones. Sunlight helps the body to produce vitamin D. Vitamin D deficiency results in rickets in children and osteomalacia in adults.
Advertisement
‘Postmenopausal women who have adequate levels of vitamin D and estradiol can keep heart disease, diabetes, and stroke risk at bay.’
Read More..
Tweet it Now
Read More..
Metabolic syndrome has emerged as a major public health concern, affecting 30% to 60% of postmenopausal women worldwide. The progression of abdominal obesity and heart disease that lead to metabolic syndrome increases significantly as women age and appears to be directly associated with estrogen loss in postmenopausal women. This has led some researchers to recommend estradiol treatment for women who are fewer than 6 years postmenopausal as a means of preventing heart disease.
Similarly, vitamin D has been associated with several markers of metabolic syndrome, including obesity, hyperglycemia, insulin resistance, and type 2 diabetes mellitus. Supplementation with vitamin D has been shown to reduce the risk of metabolic syndrome over a 20-year follow-up.
![Vitamin D Deficiency]( "Vitamin D Deficiency")
Vitamin D the sunshine vitamin is essential for strong bones. Vitamin D deficiency is reportedly increasing worldwide and cause bone pain and muscle weakness.
Because the synergistic benefits of vitamin D and estrogen are already documented to improve bone health in women, researchers in this newest study from China hypothesized that the same interaction might affect metabolic syndrome. The cross-sectional study included 616 postmenopausal women aged 49 to 86 years who were not taking estrogen and vitamin D/calcium supplements at the beginning of the trial. It concluded there was a positive correlation between vitamin D and estradiol.
Specifically, higher vitamin D was associated with a favorable lipid profile, blood pressure, and glucose level. Estradiol was negatively associated with cholesterol, triglycerides, and blood pressure. These results suggest a synergistic role of vitamin D and estradiol deficiency in developing metabolic syndrome in postmenopausal women.
Findings are published in the article "The synergistic effects of vitamin D and estradiol deficiency on metabolic syndrome in Chinese postmenopausal women."
"In this cross-sectional study, low estradiol increased the risk of metabolic syndrome in postmenopausal women who had vitamin D deficiency," says Dr. JoAnn Pinkerton, NAMS executive director.
"The Endocrine Society recommends vitamin D levels of 30 ng/mL for postmenopausal women. Whether adequate levels of vitamin D improve nonskeletal cardiovascular or cognitive benefits remains the subject of debate, and answers await randomized clinical trial data."
Source: Eurekalert
Vitamin D Deficiency
Vitamin D the sunshine vitamin is essential for strong bones. Vitamin D deficiency is reportedly increasing worldwide and cause bone pain and muscle weakness.
Advertisement
Because the synergistic benefits of vitamin D and estrogen are already documented to improve bone health in women, researchers in this newest study from China hypothesized that the same interaction might affect metabolic syndrome. The cross-sectional study included 616 postmenopausal women aged 49 to 86 years who were not taking estrogen and vitamin D/calcium supplements at the beginning of the trial. It concluded there was a positive correlation between vitamin D and estradiol.
Specifically, higher vitamin D was associated with a favorable lipid profile, blood pressure, and glucose level. Estradiol was negatively associated with cholesterol, triglycerides, and blood pressure. These results suggest a synergistic role of vitamin D and estradiol deficiency in developing metabolic syndrome in postmenopausal women.
Findings are published in the article "The synergistic effects of vitamin D and estradiol deficiency on metabolic syndrome in Chinese postmenopausal women."
"In this cross-sectional study, low estradiol increased the risk of metabolic syndrome in postmenopausal women who had vitamin D deficiency," says Dr. JoAnn Pinkerton, NAMS executive director.
"The Endocrine Society recommends vitamin D levels of 30 ng/mL for postmenopausal women. Whether adequate levels of vitamin D improve nonskeletal cardiovascular or cognitive benefits remains the subject of debate, and answers await randomized clinical trial data."
Source: Eurekalert
Link between Statins and Vitamin D
Statins, the cholesterol-lowering medications, and vitamin D appear to complement each other's effects.
Advertisement
 Estrogen May Fight against Depression after Heart AttackPeople with heart failure or heart attacks are more likely to suffer from depression. Estrogen may help fight depression after a heart attack or heart failure. | Advertisement
|
Advertisement
Recommended Reading
Latest Women Health News
In 90% of women with female genital tuberculosis condition, the fallopian tubes are affected. In around 70% uterine endometrium is affected.
Women involved in motor vehicle crashes during pregnancy were at increased risk of various adverse pregnancy outcomes, especially while riding scooters.
Are shift works bad for women's health? Yes, Women who are working rotating shifts are more likely to be frail.
Psychologists found that a pregnant woman's mindset can impact childbirth outcomes, with those viewing it as natural having fewer interventions.
The study reveals that pregnancy-related mortality rates were stable with rising COVID-19–related death rates among reproductive-age women.